{"url_path":"/sec/ardt/8-k/2026-06-02/item-7-01","section_key":"item-7-01","section_title":"Item 7.01 Regulation FD Disclosure.","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-06-02","source_url":"https://www.sec.gov/Archives/edgar/data/1756655/0001193125-26-253567-index.html","accession_number":"0001193125-26-253567","cik":"0001756655","ticker":"ARDT","issuer_name":"Ardent Health, Inc.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1756655/0001193125-26-253567-index.html","primary_entity_key":"0001756655","primary_entity_name":"Ardent Health, Inc."},"word_count":134,"has_tables":true,"body_markdown":"Item 7.01.\n\nRegulation FD Disclosure.\n\nOn June 2, 2026, the Company issued a press release in connection with the foregoing leadership transition. A copy of the press release is attached as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated herein by reference.\n\nThe information furnished with this Item 7.01, including Exhibit 99.1, shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that section, nor shall it be deemed to be incorporated by reference into any other filing under the Securities Act of 1933, as amended, or the Exchange Act, regardless of any general incorporation language in any such filing, except as expressly set forth by specific reference in such filing."}